Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
Preskorn
Sheldon H
SH
Department of Psychiatry, University of Kansas School of Medicine-Wichita, Kansas, USA.
D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001437:Bacteriuria / Q000150:complications / Q000188:drug therapy; D002939:Ciprofloxacin / Q000627:therapeutic use; D003704:Dementia / Q000175:diagnosis* / Q000534:rehabilitation; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006220:Haloperidol / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008140:Lorazepam / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*; D011595:Psychomotor Agitation / Q000188:drug therapy / Q000523:psychology; D012642:Selegiline / Q000627:therapeutic use*; D014282:Trihexyphenidyl / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D005473:Fluoxetine; D012642:Selegiline; D002939:Ciprofloxacin; D014282:Trihexyphenidyl; D006220:Haloperidol; D008140:Lorazepam